The short version
- In a randomized trial of 275 first-time hearing aid users over 50, two aids improved a 100-point benefit score by 19.7 points and one aid by 14.4.
- The authors say it is not clear whether that five-point gap matters in daily life, and by six months it was no longer significant.
- At the end, about 29% of people chose to keep one aid, and most of the rest chose two.
Audiologists at Duke and Vanderbilt randomly assigned 275 adults aged 50 and over, with age-related hearing loss and almost no hearing-aid experience, to one or two prescription aids. Participants paid for the devices and services as they would in an ordinary clinic. After three months, the one-aid group’s score on a 100-point questionnaire of everyday hearing benefit had improved by 14.4 points and the two-aid group’s by 19.7, a gap of 5.3 points (95% CI 1.8 to 8.8). The trial, led by Sherri Smith, was published in JAMA Otolaryngology in August; Smith discussed it on This Week in Hearing on November 11.
The gap was the only clear win. On the trial’s registry record, satisfaction, hours of daily use and a speech-in-noise test did not differ significantly, and by six months the main score was no longer significantly different either. The authors write that it is unclear whether five points is clinically meaningful, and that the trial does not settle two aids as the standard. “If it turns out you can really only afford one, one still provided benefit,” Smith said.
When the three months ended, about 29% of people chose to keep one aid.



